01 1Elementis SRL, Inc.
01 1Aluminum Zirconium Octachlorohydrex Gly
01 1Germany
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY
NDC Package Code : 72450-772
Start Marketing Date : 2021-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Aluminum Zirconium Glycinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aluminum Zirconium Glycinate, including repackagers and relabelers. The FDA regulates Aluminum Zirconium Glycinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aluminum Zirconium Glycinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aluminum Zirconium Glycinate supplier is an individual or a company that provides Aluminum Zirconium Glycinate active pharmaceutical ingredient (API) or Aluminum Zirconium Glycinate finished formulations upon request. The Aluminum Zirconium Glycinate suppliers may include Aluminum Zirconium Glycinate API manufacturers, exporters, distributors and traders.
click here to find a list of Aluminum Zirconium Glycinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aluminum Zirconium Glycinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aluminum Zirconium Glycinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aluminum Zirconium Glycinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aluminum Zirconium Glycinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aluminum Zirconium Glycinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aluminum Zirconium Glycinate suppliers with NDC on PharmaCompass.
We have 1 companies offering Aluminum Zirconium Glycinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?